CMS Roster Billing Streamlines Vaccine Claims for Miami Mass Immunizers, Including Baptist Hospital
Miami mass immunizers, including Baptist Hospital Of Miami Inc, can now utilize a streamlined process for submitting vaccine claims. The Centers for Medicare & Medicaid Services (CMS) introduced new information regarding roster billing for mass immunizers, which simplifies the administrative burden for high-volume vaccination efforts.
Advertisement
Miami healthcare providers, including Baptist Hospital Of Miami Inc, can now utilize a streamlined process for submitting vaccine claims. The Centers for Medicare & Medicaid Services (CMS) introduced new information regarding roster billing for mass immunizers, which simplifies the administrative burden for high-volume vaccination efforts.
This new roster billing system allows mass immunizers to submit a single claim for multiple beneficiaries. To qualify, all beneficiaries must have received the same vaccine on the same date of service. This process specifically applies to influenza virus vaccines and pneumococcal vaccines.
The change means facilities like Baptist Hospital Of Miami Inc can process claims more efficiently, potentially speeding up reimbursement and allowing them to focus more resources on patient care. The ability to bundle multiple claims into one reduces paperwork and administrative overhead, a benefit for any large-scale vaccination program.
CMS provided this new information yesterday, September 13, 2026, outlining the specifics of the roster billing method. This initiative aims to support healthcare providers who administer a high volume of specific vaccines by simplifying their billing procedures.
Healthcare providers interested in implementing this new roster billing process for influenza and pneumococcal vaccines should consult the latest CMS guidelines for detailed instructions on claim submission.
Related Topics
Article Ratings
How do you feel about this story?
Michelle Foster
Sign in to follow this author from their profile.


Discussion (0)
Join the Conversation
Join the conversation
Sign in to share your thoughts, reply to readers, and like comments.
No comments yet. Be the first to comment!